Skip to main content

Advertisement

Table 3 Proportion of patients using oral antidiabetic drugs (OHA) prior to insulin initiation and at end of study

From: Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study

  Body mass index (BMI) at baseline
  BMI <25 25 ≤ BMI < 30 30 ≤ BMI < 35 BMI ≥ 35
Biguanide     
  Baseline 71.2% 81.8% 85.8% 87.0%
  Final Visit 65.1% 80.5% 85.2% 86.5%
  Change -6.1% -1.3% -0.6% -0.5%
Glinides     
  Baseline 19.5% 16.3% 14.7% 13.5%
  Final Visit 24.7% 18.8% 17.1% 16.1%
  Change +5.2% +2.5% +2.4% +2.6%
Alpha Glucosidase Inhibitor     
  Baseline 19.9% 12.2% 8.6% 7.8%
  Final Visit 21.4% 12.5% 7.8% 6.6%
  Change +1.5% +0.3% -0.8% -1.2%
Sulphonylureas     
  Baseline 57.9% 58.5% 61.7% 60.3%
  Final Visit 41.4% 43.3% 46.4% 45.3%
  Change -16.5% -15.2% -15.3% -15.0%
Thiazolidinediones     
  Baseline 10.9% 11.3% 12.8% 15.2%
  Final Visit 7.3% 7.9% 7.7% 8.2%
  Change -3.6% -3.4% -5.1% -7.0%
Dipeptidyl peptidase IV Inhibitors     
  Baseline 3.8% 5.9% 7.9% 9.6%
  Final Visit 2.8% 5.2% 6.5% 7.2%
  Change -1.0% -0.7% -1.4% -2.4%